In an article written this summer, Louis Kyron put forth a theory that the legalization of the recreational market would in fact cause an increase in medical patients … people who were reluctant to have that conversation with their medical team previously would now feel comfortable doing so once legalized and similarly medical professionals may feel less apprehensive about recommending medical cannabis once it was “officially” legal. As we know, he was pretty much alone there with most predicting the medical stream would erode. Recent news on this along with discussing directly with LPs suggests in fact Louis was right with LPs reporting substantial patient growth.
From FSD’s perspective first and then from an Investor’s perspective, why is that significant – a strong healthy growing medical stream side by side with a strong growing healthy recreational stream?
The legalization of recreational cannabis has removed a stigma for new consumers that felt uncomfortable with plant still illegal and such a close association with the black market. Legalization has opened doors for physicians to better educate patients on medicinal cannabis uses with more research available. The key opportunity in the medical side is consumer education and converting patients from previous prescribed drugs. One of FSD Pharma’s future propositions and we have seen with other LPs is acquiring medical clinics, physiotherapy clinics, and pain rehabilitation centres with the intention to convert existing patients from traditional pharmaceutical drugs to medical cannabis with education. Investors in recreational market are well aware the largest producers will dominate that market as a commodity with prices dropping. The big money to be made will be in the pharma side with patents and proprietary medical applications that require extensive research and development. FSD Pharma will cover all aspects of the cannabis industry but will have a focus on the pharma side, hence the company name “pharma”.
So while we are discussing the medical stream … FSD is very involved on a number of fronts whether it be what to many is a preferred delivery system for medical dosing (pills) as well as your ground-breaking research on Irritable Bowel Syndrome (IBS) and your research on the “Steady Stomach” formulation. First of all – well done on each
149